Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2022-09-09 00:00:00 ET · period of report 2022-09-07 · accession 0001209191-22-049316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-09 | 2022-09-07+ | VERA | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +21.9K | 196.3K | +13% | +$63.5K |
| DM | 2022-09-09 | 2022-09-07+ | VERA | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $20.37 | -21.9K | 181.2K | -11% | -$445.9K |
| DM | 2022-09-09 | 2022-09-07+ | VERA | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $0.00 | -21.9K | 1.03M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-09-07 | M | A | 6,785 | $2.90 | 187,935 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-09-08 | S | D | 15,106 | $20.52 | 181,150 | D | — | — | (F3) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2022-09-08 | M | A | 15,106 | $2.90 | 196,256 | D | — | — | |
| 4 | Common | Class A Common Stock | 2022-09-07 | S | D | 6,785 | $20.03 | 181,150 | D | — | — | (F2) The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.28, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-09-07 | M | D | 6,785 | $0.00 | 1,049,131 | D | $2.90 · — to 2030-12-15 | 6,785 Class A Common Stock | (F4) 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-09-08 | M | D | 15,106 | $0.00 | 1,034,025 | D | $2.90 · — to 2030-12-15 | 15,106 Class A Common Stock | (F4) 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter. |